Given the role of brain DNA methylation in memory and AD [15], confirmation of the epigenetic impacts associated with MTHFR and SLC19A1/RFC1 gene mutations as markers for MCI or AD could open new potential research domains for the prevention and treatment of dementia in the elderly [16]. Here, MTHFR is linked to Alzheimer disease.